Unilateral Presumed Ocular Histoplasmosis Syndrome–Like Multifocal Chorioretinopathy With Type 2 Choroidal Neovascularization in a Patient Without Recognized Endemic Exposure: A Case Report
Case Reports in Ophthalmological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crop/7020150 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Ophthalmological Medicine, online erschienen am 14.11.2026. Verfasst von Jennifer Abou Chaar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology Faculty of Medicine and Medical Sciences University of Balamand Beirut Lebanon balamand.edu.lb. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Presumed ocular histoplasmosis syndrome (POHS) is a clinical diagnosis defined by peripapillary atrophy, punched‐out chorioretinal scars, and choroidal neovascularization (CNV) in an eye without intraocular inflammation, and is classically linked to residence in regions endemic for Histoplasma capsulatum . A 24‐year‐old healthy, emmetropic woman presented with a 6‐month history of a central scotoma in the left eye. Best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/100 in the left. She had lived only in Lebanon and France and had no recognized exposure to a highly endemic region. The left fundus showed peripapillary atrophy, multiple punched‐out midperipheral chorioretinal scars including a curvilinear (Schlaegel) streak, and a juxtafoveal Type 2 CNV, without anterior chamber or vitreous cells; the right eye was clinically normal. Indocyanine green angiography showed hypocyanescent lesions exceeding those visible clinically, a finding shared with multifocal choroiditis and punctate inner choroidopathy. An infectious and inflammatory work‐up, including Histoplasma serology, was negative. Three loading doses of intravitreal aflibercept restored BCVA to 20/20. Asymptomatic recurrence 1 month later (BCVA 20/50) was controlled with a treat‐and‐extend regimen; over 20 months and 16 visits, the eye remained free of intraocular inflammation, and the fellow eye remained clinically normal. The case fulfills Standardization of Uveitis Nomenclature classification criteria for multifocal choroiditis with panuveitis; because its etiology could not be established, we describe its clinical phenotype as POHS‐like. Such a phenotype can occur outside recognized endemic areas; its neovascular complication responds well to anti‐VEGF therapy but may recur, warranting structured imaging surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology Faculty of Medicine and Medical Sciences University of Balamand Beirut Lebanon balamand.edu.lb.
- Department of Ophthalmology Clemenceau Medical Center Beirut Lebanon cmc.com.lb.
ORCID-Profile: Jennifer Abou Chaar, Anthony Daher, Yehya Tlaiss
Zitieren
APA
Chaar, J. A., Daher, A., Tlaiss, Y., & Jaroudi, M. (2026). Unilateral Presumed Ocular Histoplasmosis Syndrome–Like Multifocal Chorioretinopathy With Type 2 Choroidal Neovascularization in a Patient Without Recognized Endemic Exposure: A Case Report. Case Reports in Ophthalmological Medicine, 2026(1). https://doi.org/10.1155/crop/7020150
Vancouver
Chaar JA, Daher A, Tlaiss Y, Jaroudi M. Unilateral Presumed Ocular Histoplasmosis Syndrome–Like Multifocal Chorioretinopathy With Type 2 Choroidal Neovascularization in a Patient Without Recognized Endemic Exposure: A Case Report. Case Reports in Ophthalmological Medicine. 2026;2026(1). doi:10.1155/crop/7020150
BibTeX
@article{Chaar2026,
author = {Chaar, Jennifer Abou and Daher, Anthony and Tlaiss, Yehya and Jaroudi, Mahmoud},
title = {Unilateral Presumed Ocular Histoplasmosis Syndrome–Like Multifocal Chorioretinopathy With Type 2 Choroidal Neovascularization in a Patient Without Recognized Endemic Exposure: A Case Report},
journal = {Case Reports in Ophthalmological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crop/7020150}
}
EUVIMED